Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (267)	9/22/2000 7:50:27 PM
From: tom pope	Respond to of 1833

>>Has anyone called the Cadus people recently? << Don't you mean the Cadus person(g)?

To: BulbaMan who wrote (267)	9/22/2000 7:52:21 PM
From: Tomato	Read Replies (2) \| Respond to of 1833

Don't think it takes too much to hold the price down, as it seems only about 8000 shares trade per day. Seems like not many people want to sell or buy. I'd buy more, but I'm a little leery of the illiquidity. Anyone: When you add the royalty stream and the stock held in Axiom to the equation, how much do you get as a value per share?

To: BulbaMan who wrote (267)	9/24/2000 11:32:01 AM
From: tom pope	Read Replies (1) \| Respond to of 1833

>>Wouldn't it it be nice if, whenever Carl makes the news, they noted that he was a major shareholder of Cadus?<< Today's NYT, article on Icahn, didn't mention Cadus. Not really surprising - Cadus is pretty small beer by Carl's standards. The only thing even remotely related to Cadus was the info that he has his office in the GM building which happens to be where Cadus leases its New York office. Duh, I guess. BTW, I noticed that Yahoo now reports zero institutional ownership.